Analyzing K2M Group Holdings (KTWO) & Orthofix International N.V. (OFIX)
K2M Group Holdings (NASDAQ: KTWO) and Orthofix International N.V. (NASDAQ:OFIX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability and analyst recommendations.
This is a summary of recent ratings and target prices for K2M Group Holdings and Orthofix International N.V., as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|K2M Group Holdings||0||0||8||1||3.11|
|Orthofix International N.V.||0||0||5||0||3.00|
K2M Group Holdings presently has a consensus price target of $25.13, indicating a potential upside of Infinity. Orthofix International N.V. has a consensus price target of $53.30, indicating a potential upside of 4.18%. Given K2M Group Holdings’ stronger consensus rating and higher probable upside, equities analysts plainly believe K2M Group Holdings is more favorable than Orthofix International N.V..
This table compares K2M Group Holdings and Orthofix International N.V.’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|K2M Group Holdings||-16.22%||-15.89%||-10.71%|
|Orthofix International N.V.||0.33%||10.26%||7.57%|
Valuation and Earnings
This table compares K2M Group Holdings and Orthofix International N.V.’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||NetIncome||Earnings Per Share||Price/Earnings Ratio|
|K2M Group Holdings||$236.63||0.00||-$41.66||($0.97)||N/A|
|Orthofix International N.V.||$409.79||2.27||$3.05||$0.07||730.96|
Orthofix International N.V. has higher revenue and earnings than K2M Group Holdings. K2M Group Holdings is trading at a lower price-to-earnings ratio than Orthofix International N.V., indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
99.1% of K2M Group Holdings shares are owned by institutional investors. Comparatively, 93.8% of Orthofix International N.V. shares are owned by institutional investors. 5.8% of K2M Group Holdings shares are owned by insiders. Comparatively, 5.6% of Orthofix International N.V. shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Risk & Volatility
K2M Group Holdings has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500. Comparatively, Orthofix International N.V. has a beta of 0.15, indicating that its share price is 85% less volatile than the S&P 500.
K2M Group Holdings beats Orthofix International N.V. on 7 of the 13 factors compared between the two stocks.
K2M Group Holdings Company Profile
K2M Group Holdings, Inc. is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor. Its products consist of implants, disposables and instruments, which are marketed and sold primarily to hospitals for use by spine surgeons. As of December 31, 2016, its product portfolio consisted of 83 product lines that are used in complex spine, minimally invasive surgery (MIS) and degenerative surgeries. Its technologies include EVEREST, MESA, Rail 4D, Quicket Deformity, CASCADIA, CAPRI, SERENGETI, RAVINE and tifix. Its degenerative spine technologies are used to treat degenerative spine disorders and include products, such as cervical, thoracic and lumbar spinal fusion devices and interbody devices.
Orthofix International N.V. Company Profile
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. The Biologics products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution and VersaShield. The Extremity Fixation products include Fixator, Eight-Plate Guided Growth System and Contours VPS Volar Plating System III. The Spine Fixation products include Hallmark Anterior Cervical Plate System, Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, Firebird Deformity Correction System, Phoenix Minimally Invasive Spinal Fixation System, Samba-Screw System, LONESTAR Cervical Stand Alone (CSA), SKYHAWK Lateral Interbody Fusion System & Lateral Plate System and CENTURION POCT System.
Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.